{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:27:44Z","timestamp":1780637264205,"version":"3.54.1"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The injectable glucagon-like peptide-1 (GLP-1) receptor agonist (RA) drugs are commonly used for weight loss among reproductive-aged women but the perception of their impact on fertility is not clear among the public.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objectives<\/jats:title>\n<jats:p>The purpose of this review was to compare scientific literature to social media discourse and online search pertaining to the potential impact of GLP-1 RAs on female fertility.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Group 1 included 3 social media platforms, each of which required a different data collection method. For Reddit, VADER (Communalytic \u00ae) was used as a sentiment analyzer and for Twitter and TikTok, we performed a manual search for posts and scored them using an objective internal scale. Group 2 included the online search engine Google Trends. Group 3 consisted of medical literature search by PubMed. All sentiments of posts\/comments\/articles were graded as: \u201cPositive, Neutral, or Negative\u201d and compared among groups.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>In Groups 1 and 2, scores showed a significantly more Positive than Neutral, and more Neutral than Negative sentiments. In Group 3, among the 52 original studies found on PubMed in women with polycystic ovary syndrome (PCOS), they all had Positive sentiments. In Groups 1, 2, and 3, there was a strong positive correlation among all sentiments (r<jats:sup>2<\/jats:sup>\u2009=\u20090.83). Even though all 3 social media platforms had the majority of posts with a Positive sentiment and correlated with Google Trends posts and with PubMed studies in women with PCOS (r<jats:sup>2\u2009<\/jats:sup>=\u20090.74), there was a lack of PubMed studies pertaining to the effect of GLP-1 RA in women without PCOS.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The Positive sentiments among women without PCOS is not justified by evidence-based medicine and there is a clear need for studies pertaining to this topic.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0326210","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T17:23:54Z","timestamp":1751477034000},"page":"e0326210","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["GLP-1 receptor agonist for weight loss and fertility: Social media and online perception versus evidence-based medicine"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7952-1428","authenticated-orcid":true,"given":"Zaher","family":"Merhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6752-1191","authenticated-orcid":true,"given":"Manasi","family":"Karekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mouanness","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"pone.0326210.ref001","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"DJ Drucker","year":"2018","journal-title":"Cell Metab"},{"issue":"15","key":"pone.0326210.ref002","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes","volume":"390","author":"MN Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"pone.0326210.ref003","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and Renal Outcomes in Type 2 Diabetes","volume":"377","author":"JFE Mann","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"pone.0326210.ref004","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-Weekly Semaglutide in Adults with Overweight or Obesity","volume":"384","author":"JPH Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"pone.0326210.ref005","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"M Davies","year":"2021","journal-title":"Lancet"},{"key":"pone.0326210.ref006","doi-asserted-by":"crossref","first-page":"102427","DOI":"10.1016\/j.npep.2024.102427","article-title":"Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY3-36 in the suppression of food, drug-seeking, and anxiogenesis","volume":"105","author":"Y Dumiaty","year":"2024","journal-title":"Neuropeptides"},{"issue":"5","key":"pone.0326210.ref007","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2352-4642(23)00033-0","article-title":"Semaglutide and social media: implications for young women with polycystic ovarian syndrome","volume":"7","author":"SK Keating","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"issue":"12","key":"pone.0326210.ref008","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(22)00318-7","article-title":"Social media and misinformation in diabetes and obesity","volume":"10","author":"T Burki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"pone.0326210.ref009","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2017.11.004","article-title":"Incretins modulate progesterone biosynthesis by regulating bone morphogenetic protein activity in rat granulosa cells","volume":"178","author":"Y Nishiyama","year":"2018","journal-title":"J Steroid Biochem Mol Biol"},{"key":"pone.0326210.ref010","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa285","article-title":"Obesity, polycystic ovary syndrome, and infertility: a new avenue for GLP-1 receptor agonists","volume":"105","author":"H Cena","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"pone.0326210.ref011","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.rbmo.2019.04.017","article-title":"GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis","volume":"39","author":"Y Han","year":"2019","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"pone.0326210.ref012","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/humupd\/dmz019","article-title":"The role of glucagon-like peptide-1 in reproduction: from physiology to therapeutic perspective","volume":"25","author":"M Jensterle","year":"2019","journal-title":"Hum Reprod Update"},{"issue":"3","key":"pone.0326210.ref013","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.repbio.2019.07.003","article-title":"Liraglutide treatment effects on rat ovarian and uterine tissues","volume":"19","author":"SM Saber","year":"2019","journal-title":"Reprod Biol"},{"issue":"11","key":"pone.0326210.ref014","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1210\/en.2014-1978","article-title":"GLP-1 Increases Preovulatory LH Source and the Number of Mature Follicles, As Well As Synchronizing the Onset of Puberty in Female Rats","volume":"156","author":"V Outeiri\u00f1o-Iglesias","year":"2015","journal-title":"Endocrinology"},{"issue":"1","key":"pone.0326210.ref015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuropharm.2009.06.015","article-title":"Age-related LH surge dysfunction correlates with reduced responsiveness of hypothalamic anteroventral periventricular nucleus kisspeptin neurons to estradiol positive feedback in middle-aged rats","volume":"58","author":"MA Lederman","year":"2010","journal-title":"Neuropharmacology"},{"issue":"5","key":"pone.0326210.ref016","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/10810730.2018.1465493","article-title":"I Sought It, I Reddit: Examining Health Information Engagement Behaviors among Reddit Users","volume":"23","author":"RA Record","year":"2018","journal-title":"J Health Commun"},{"issue":"11","key":"pone.0326210.ref017","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/brainsci13111503","article-title":"GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach","volume":"13","author":"D Arillotta","year":"2023","journal-title":"Brain Sci"},{"issue":"11","key":"pone.0326210.ref018","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.17219\/acem\/151695","article-title":"GLP-1 receptor agonists, polycystic ovary syndrome and reproductive dysfunction: Current research and future horizons","volume":"31","author":"GS Papaetis","year":"2022","journal-title":"Adv Clin Exp Med"},{"issue":"9","key":"pone.0326210.ref019","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1080\/17512433.2021.1933433","article-title":"Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome","volume":"14","author":"M Siamashvili","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"pone.0326210.ref020","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"HJ Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"pone.0326210.ref021","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12185915","article-title":"Do GLP-1 analogs have a place in the treatment of PCOS? New insights and promising therapies","volume":"12","author":"A Szczesnowicz","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"pone.0326210.ref022","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/biolre\/ioad032","article-title":"Glucagon-like peptide-1 receptor agonists decrease hyperinsulinemia and hyperandrogenemia in dehydroepiandrosterone-induced polycystic ovary syndrome mice and are associated with mitigating inflammation and inducing browning of white adipose tissue\u2020","volume":"108","author":"Y Zhang","year":"2023","journal-title":"Biol Reprod"},{"key":"pone.0326210.ref023","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084334","article-title":"The Role of Glp-1 Receptor Agonists in Insulin Resistance with Concomitant Obesity Treatment in Polycystic Ovary Syndrome","volume":"23","author":"K Bednarz","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"pone.0326210.ref024","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2022.04.027","article-title":"Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study","volume":"118","author":"KE Elkind-Hirsch","year":"2022","journal-title":"Fertil Steril"},{"key":"pone.0326210.ref025","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12010067","article-title":"Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS","volume":"12","author":"E Reiser","year":"2022","journal-title":"J Clin Med"},{"key":"pone.0326210.ref026","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/DMSO.S451129","article-title":"Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention","volume":"17","author":"C Xiong","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"pone.0326210.ref027","doi-asserted-by":"crossref","first-page":"556","DOI":"10.3390\/nu15030556","article-title":"Effects of a Dulaglutide plus Calorie-Restricted Diet versus a Calorie-Restricted Diet on Visceral Fat and Metabolic Profiles in Women with Polycystic Ovary Syndrome: A Randomized Controlled Trial","volume":"15","author":"Y Zhang","year":"2023","journal-title":"Nutrients"},{"issue":"12","key":"pone.0326210.ref028","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1210\/en.2019-00450","article-title":"Effect of GLP-1 Receptor Agonists in the Cardiometabolic Complications in a Rat Model of Postmenopausal PCOS","volume":"160","author":"ED Torres Fernandez","year":"2019","journal-title":"Endocrinology"},{"issue":"1","key":"pone.0326210.ref029","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF03401383","article-title":"A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome","volume":"14","author":"M Jensterle","year":"2015","journal-title":"Hormones (Athens)"},{"issue":"5","key":"pone.0326210.ref030","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00404-022-06700-3","article-title":"Effect of metformin and exenatide on pregnancy rate and pregnancy outcomes in overweight or obese infertility PCOS women: long-term follow-up of an RCT","volume":"306","author":"R Li","year":"2022","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"pone.0326210.ref031","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/dom.13053","article-title":"Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial","volume":"20","author":"S Fr\u00f8ssing","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"pone.0326210.ref032","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/dom.14944","article-title":"Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity","volume":"25","author":"M Jensterle","year":"2023","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"pone.0326210.ref033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-18-0175","article-title":"Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study","volume":"179","author":"V Salamun","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"pone.0326210.ref034","first-page":"1484321","article-title":"GLP-1\/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites","volume":"2020","author":"Z Sun","year":"2020","journal-title":"Int J Endocrinol"},{"key":"pone.0326210.ref035","doi-asserted-by":"crossref","first-page":"170624","DOI":"10.1016\/j.peptides.2021.170624","article-title":"Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats","volume":"145","author":"L-M Wu","year":"2021","journal-title":"Peptides"},{"key":"pone.0326210.ref036","article-title":"Letter to \u201cTreating obesity and fertility in the era of glucagon-like peptide 1 receptor agonists\u201d","author":"Z Merhi","year":"2024","journal-title":"Fertil Steril"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T17:24:03Z","timestamp":1751477043000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326210"}},"subtitle":[],"editor":[{"given":"Natural Hoi Sing","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":36,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0326210","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}